28 funds hold it.Insiders net selling.
Net selling: insiders sold $1.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 5, 2026
Financial period
Q4 FY2026
Earnings per share
$4.07 expected
Revenue
$5.11B expected
Estimates as of Nov 6, 2026
EPS expected
$2.60 to $3.01
Revenue expected
9 analysts
Last 30 days
Analysts raising estimates
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 5, 2026 | $4.15est. $4.07 | +2.02%beat | $5.27Best. $5.11B+3.14% | -10.5%from $5.89B |
| Jun 30, 2026Reported Aug 6, 2026 | $3.23est. $3.14 | +2.93%beat | $4.98Best. $4.89B+1.91% | +5.4%from $4.73B |
| Mar 31, 2026Reported May 7, 2026 | $2.90est. $2.77 | +4.51%beat | $4.71BCompany release | +5.2%from $4.48B |
| Dec 31, 2025Reported Feb 9, 2026 | $2.91est. $2.81 | +3.47%beat | $5.25BSEC filing | +1.6%from $5.17B |
| Sep 30, 2025Reported Nov 6, 2025 | $3.96est. $3.92 | +1.02%beat | $5.89BAlpha Vantage | +8.3%from $5.44B |
| Jun 30, 2025Reported Aug 7, 2025 | $3.68est. $3.40 | +8.24%beat | $4.73BSEC filing | -5.3%from $4.99B |
| Mar 31, 2025Reported May 1, 2025 | $3.35est. $3.28 | +2.13%beat | $4.48BSEC filing | -11.2%from $5.04B |
| Dec 31, 2024Reported Feb 5, 2025 | $3.43est. $2.99 | +14.72%beat | $5.17BSEC filing | +9.8%from $4.71B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.89B | $5.25B | $4.71B | $4.98B |
| Cost of what it sold | $3.09B | $2.91B | $2.56B | $2.67B |
| Gross profit | $2.80B | $2.34B | $2.15B | $2.31B |
| What it spent | ||||
| Research and development | $322.0M | $318.0M | $249.0M | $258.0M |
| Sales and admin | $1.37B | $1.43B | $1.21B | $1.26B |
| Other operating costs | $414.0M | — | $599.0M | $133.0M |
| Total operating expenses | $2.10B | $1.75B | $2.06B | $1.65B |
| What was left | ||||
| Operating profit | $697.0M | $594.0M | $94.0M | $663.0M |
| Interest on debt | $155.0M | $107.0M | $149.0M | $132.0M |
| Profit before tax | $510.0M | $487.0M | $39.0M | $554.0M |
| Tax | $17.0M | $105.0M | $76.0M | $103.0M |
| Net profit | $493.0M | $382.0M | -$311.0M | $377.0M |
| EBITDA | $1.29B | $1.21B | $709.0M | $1.25B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
West Pharmaceutical Services (WST) Raises 2026 Outlook On Earnings Strength As Fair Value Debate Builds
NeutralNov 6This Centrus Energy Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
BullishNov 6Buy, Sell, or Hold? Friday's Top Upgrades and Downgrades: Becton Dickinson, BJ's Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More
NeutralNov 63 Stocks in Focus That Hiked Dividends Amid Ongoing Market Volatility
BullishNov 6Becton, Dickinson and Company Q4 Earnings Call Highlights
Leans bullishNov 6Becton, Dickinson Raises Quarterly Dividend 1% to $1.06 Per Share
BullishNov 6Becton Dickinson and (BDX) Stock Price, Chart & Analysis
NeutralNov 6BD Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
BullishNov 532 macro signals shaping BDX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results